rediff.com

NewsApp (Free)

Read news as it happens
Download NewsApp

Available on  

Rediff News  All News 

Dcgi Singh

Rediff.com  »  News  »   Dcgi Singh

  News for Dcgi Singh

  • Business

Why is Novartis likely to lose Tiamulin drug licence?

Swiss drug maker Novartis is likely to face legal action for allegedly faking documents to seek registration of its veterinary product Tiamulin Hydrogen Fumarate (80 per cent granules) in India.......

Ranbaxy whistle-blower to talk on quality of Made-in-India drugs

The concerns surrounding drug manufacturing practices in India appear to have reached foreign shores, beyond the international regulators’ domain.  Ranbaxy whistle-blower Dinesh Thakur,......

Keep us in loop before any FDA swoop, India tells US

Inspections only in domestic authorities’ presence, visiting US drug regulator told Taking a tough stand on the ongoing regulatory issues faced by the domestic pharmaceutical industry because......

After ban on drug facilities, US regulator comes calling

Margaret A Hamburg, the first commissioner of the US Food and Drug Administration (US FDA) to visit India officially, will meet heads of major domestic pharma companies such as Ranbaxy, Wockhardt,......

Biocon contests Roche claims on cancer drug

Biocon has lashed out at Roche a day after the Swiss company secured an order from the Delhi High Court barring the Indian company from marketing its new drug, co-developed with Mylan, as a......
  Web results for Dcgi Singh
Export rule eased for medical device makers

The government has decided to increase the validity of free sale certificates required by domestic medical device manufacturers for exports. Now,... ...

http://smartinvestor.business-standard.com/market/Marketnews-381012-Marketnewsdet-Export_rule_eased_for_medical_device_makers.htm
Biocon, Mylan to challenge Delhi HC interim order on breast cancer drug

The order does not have material impact on the company as it was not prevented from selling the product, says Biocon Hyderabad: Biocon Ltd and its... ...

http://www.livemint.com/Companies/7eyUjWUeZzjdFxFpkt6htN/Biocon-Mylan-to-challenge-Delhi-HC-interim-order-on-breast.html
Health experts welcome ease of clinical trials for academic research

Before the amendment, researchers had to seek approval from DCGI for clinical trials for academic purpose New Delhi: Health experts and research... ...

http://www.livemint.com/Politics/3aOjiiQairQSrKVxi1Lx4H/Health-experts-welcome-ease-of-clinical-trials-for-academic.html
A portal for progress?

It is only five months since India's central drug authority launched its online licensing services portal, SUGAM. But the regulator needs to settle... ...

http://www.financialexpress.com/article/pharma/cover-story/a-portal-for-progress/239516/
High level Indian delegation visits US FDA to resolve issues faced by pharma exporters

A high-level Indian delegation, led by Sudhanshu Pandey, joint secretary in the Union ministry of commerce and industry, recently visited US FDA... ...

http://www.pharmabiz.com/NewsDetails.aspx?aid=94621&sid=1

Related Tags


  1. gujarat
  2. bjp
  3. india
  4. lok sabha
  5. supreme court
  6. upa
  7. bharatiya janata party
  8. congress
  9. new delhi
  10. united progressive alliance
  11. ahmedabad
  12. sonia gandhi
  13. nda
  14. rahul gandhi
  15. rajnath singh
  16. nitin gadkari
  17. delhi
  18. manmohan singh
  19. bihar
  20. national democratic alliance
  21. jd-u
  22. nitish kumar
  23. rashtriya swayamsevak sangh
  24. uttar pradesh
  25. photo
  26. advani
  27. central bureau of investigation
  28. rss
  29. janata dal-united
  30. ips

Top Coverage News


Coming to India and making

Success in manufacturing is not just about being cheap - cheap labour, cheap land, cheap power...
Broswe by: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z